[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Point of Care Molecular Diagnostics Market Research Report 2022-2032

January 2023 | 164 pages | ID: GACA2ABE7F53EN
Fatpos Global

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Point of Care Molecular Diagnostics Market to surpass USD 7.6 billion by 2032 from USD 3.2 billion in 2022 at a CAGR of 9.2 % throughout the forecast period 2022-32.

Market Overview

Fatpos Global has released a report titled Point of Care Molecular Diagnostics Market- Analysis of Market Size, Share & Trends for 2016 - 2022 and Forecasts to 2032 which is anticipated to reach Market Value According to a study by Fatpos Global. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market

Key Companies Profiled
  • Abbott Laboratories
  • Bayer AG
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Nova Biomedical
  • OraSure Technologies, Inc.
  • Qiagen Gmbh
  • Sekisui Medical Co., Ltd.
  • Zoetis Inc.
  • Other Prominent Players
Segmentation
  • By Product & Service
    • Assays & Kits
    • Instruments & Analyzers
    • Software & Services
  • By Technology
    • RT-PCR
    • INAAT
    • Other Technologies
  • By Application
    • Respiratory Diseases
    • Sexually Transmitted Diseases
    • Hospital-acquired Infections
    • Cancer
    • Hepatitis
    • Gastrointestinal Disorders
    • Other Applications
  • By End-User
    • Physicians’ Offices
    • Hospitals & ICUs
    • Research Institutes
    • Other End Users
  • Point of Care Molecular Diagnostics Market Dynamics
  • Point of Care Molecular Diagnostics Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints
Source:- Farpos Global

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
  • COVID-19 pre and post-business impact analysis
  • Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • What is the Point of Care Molecular Diagnostics Market growth?
  • Which segment accounted for the largest Point of Care Molecular Diagnostics Market share?
  • Who are the key players in the Point of Care Molecular Diagnostics Market?
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered.
  • Potential and niche segments, geographical regions exhibiting promising growth.
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.
Source:- Farpos Global

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY

2. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. AVERAGE PRICING ANALYSIS

5. MACRO-ECONOMIC INDICATORS

6. MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9. RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. POINT OF CARE MOLECULAR DIAGNOSTICS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
  12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
  12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
  Abbott Laboratories
  Bayer AG
  BioMerieux SA
  Bio-Rad Laboratories, Inc.
  Danaher Corporation
  F. Hoffmann-La Roche Ltd.
  Nova Biomedical
  OraSure Technologies, Inc.
  Qiagen Gmbh
  Sekisui Medical Co., Ltd.
  Zoetis Inc.
  Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications